SCHEMBL8955938

SCHEMBL8955938

C[C@H](Nc1csc(N)n1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
GABRA5 P31644 1/20 0.41
GABRB2 P47870 1/20 0.41
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 2/20 0.38
SCN9A Q15858 2/20 0.38
FPR2 P25090 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NOS1 P29475 1/20 0.37
MEN1 O00255 4/20 0.36
MAPT P10636 4/20 0.36
KMT2A Q03164 4/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
PIK3CG P48736 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9725667 0.83 ALDH1A1 (0.43) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
SCHEMBL22190025 0.74 CDK5 (0.54) ALDH1A1KDM4ESMN1; SMN2MEN1MAPT
SCHEMBL22190034 0.73 CDK5 (0.41) LMNA
SCHEMBL27851069 0.73 HSD17B10 (0.47) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
SCHEMBL1565803 0.72 HSD17B10 (0.46) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
SCHEMBL2642609 0.72 PIK3CG (0.53) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL1758691 0.70 HSD17B10 (0.44) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
SCHEMBL10537469 0.70 GABRA5 (0.44) HSD17B10GABRA5GABRB2ALDH1A1KDM4E
SCHEMBL22190003 0.70 PDE10A (0.50) HSD17B10ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL31494704 0.70 AKR1B1 (0.36) HSD17B10ALDH1A1SCN9AFPR2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0581899-A4 IMPROVED PROCESS FOR THE PREPARATION OF 1S-(1R*, 2S*, 3R*))-N-(4-(MORPHOLINYLSULFONYL)-L-PHENYLALANYL-3-(2-AMINO-4-THIAZOLYL)-N- (1-CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL)-L-ALANINAMIDE WARNER LAMBERT CO (US) 1996-10-02 EP disclosed
EP-0581899-A1 IMPROVED PROCESS FOR THE PREPARATION OF 1S-(1R*, 2S*, 3R*)]-N-(4-(MORPHOLINYLSULFONYL)-L-PHENYLALANYL-3-(2-AMINO-4-THIAZOLYL)-N- (1-CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L-ALANINAMIDE WARNER-LAMBERT COMPANY (US) 1994-02-09 EP disclosed
EP-0581899-A1 IMPROVED PROCESS FOR THE PREPARATION OF 1S-(1R*, 2S*, 3R*)]-N-(4-(MORPHOLINYLSULFONYL)-L-PHENYLALANYL-3-(2-AMINO-4-THIAZOLYL)-N- (1-CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L-ALANINAMIDE WARNER-LAMBERT COMPANY (US) 1994-02-09 EP disclosed
US-5268483-A Process for the preparation of an L-alanine compound WARNER-LAMBERT COMPANY (US) 1993-12-07 US disclosed
US-5268483-A Process for the preparation of an L-alanine compound WARNER-LAMBERT COMPANY (US) 1993-12-07 US disclosed
US-5220031-A Process for the preparation of [1S-(1R*,2S*3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide WARNER-LAMBERT COMPANY (US) 1993-06-15 US disclosed
US-5220031-A Process for the preparation of [1S-(1R*,2S*3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide WARNER-LAMBERT COMPANY (US) 1993-06-15 US disclosed
WO-1992018486-A1 IMPROVED PROCESS FOR THE PREPARATION OF [1S-(1R*, 2S*, 3R*)]-N-(4-(MORPHOLINYLSULFONYL)-L-PHENYLALANYL-3-(2-AMINO-4-THIAZOLYL)-N-[(1-CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L-ALANINAMIDE WARNER-LAMBERT COMPANY (US) 1992-10-29 WO disclosed
WO-1992018486-A1 IMPROVED PROCESS FOR THE PREPARATION OF [1S-(1R*, 2S*, 3R*)]-N-(4-(MORPHOLINYLSULFONYL)-L-PHENYLALANYL-3-(2-AMINO-4-THIAZOLYL)-N-[(1-CYCLOHEXYLMETHYL)-2,3-DIHYDROXY-5-METHYLHEXYL]-L-ALANINAMIDE WARNER-LAMBERT COMPANY (US) 1992-10-29 WO disclosed
US-5089616-A Process for the preparation of [1S-(1R*,2S*,3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide WARNER-LAMBERT COMPANY (US) 1992-02-18 US disclosed
US-5089616-A Process for the preparation of [1S-(1R*,2S*,3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide WARNER-LAMBERT COMPANY (US) 1992-02-18 US disclosed